Anti-properdin antibodies, and methods for making and using same

Details for Australian Patent Application No. 2005305019 (hide)

Owner Abgenix, Inc.

Inventors Zapata, Gerardo; Gazit-Bornstein, Gadi; Yang, Xiao-Dong; Senaldi, Giorgio; Keyt, Bruce

Agent Davies Collison Cave

Pub. Number AU-A-2005305019

PCT Pub. Number WO2006/052591

Priority 10/981,300 03.11.04 US

Filing date 2 November 2005

Wipo publication date 18 May 2006

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/44 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material not provided for elsewhere

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/052591 Priority application(s): WO2006/052591

18 October 2007 Assignment before Grant

  Abgenix, Inc. The application has been assigned to Amgen Fremont Inc. Assignments before Grant, Section 113 2006

5 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005305021-Device and method for delivering an oral care agent

2005305012-Compositions and methods for purifying nucleic acids from stabilization reagents